Citation Impact
Citing Papers
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Recombinant and Natural Human Interferons: Analysis of the Incidence and Clinical Impact of Neutralizing Antibodies
2011
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
No health without mental health
2007 Standout
Electroencephalography.
1994
Apoptosis in the nervous system
2000 StandoutNature
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Sjögren's syndrome
2005 Standout
Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques
1998
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Glutamate uptake
2001 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
2015
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
ATP mediates rapid microglial response to local brain injury in vivo
2005 Standout
Preclinical safety testing of biotechnology-derived pharmaceuticals
2004
Multiple sclerosis
2008 Standout
Immunomodulatory Agents for the Treatment of Relapsing Multiple Sclerosis
2002
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
2003
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
2002
Diagnostic criteria for multiple sclerosis
2001 Standout
Heme Oxygenase-1 Dysregulation in the Brain: Implications for HIVAssociated Neurocognitive Disorders
2014
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
2013
The development of animal model systems for HIV-1 encephalitis and its associated dementia
1995
Multiple Sclerosis
2000 Standout
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
2007
Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-Type-1 infected individuals
1995
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
2005 StandoutNature
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Viral load and neuropathology in the SIV model
1999 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Interferons in relapsing remitting multiple sclerosis: a systematic review
2003
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Multiple sclerosis
2002 Standout
Recent progress in the diagnosis and treatment of multiple sclerosis
1999
Poliovirus induces indoleamine‐2,3‐dioxygenase and quinolinic acid synthesis in macaque brain
1992
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS
2002
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
2002 Standout
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
1999
The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy
2000
Recommendations for the clinical use of somatosensory-evoked potentials
2008 Standout
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Effects of feline immunodeficiency virus on astrocyte glutamate uptake: Implications for lentivirus-induced central nervous system diseases
1998
Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
2000
Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
2002 Standout
Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis
2007 Standout
Heme-Containing Oxygenases
1996 Standout
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Michael E. Coats being referenced
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
1998
Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects
1993
Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals
1992